A Gary Lyons

Affiliations

  • Director at Neurocrine Biosciences Inc (NBIX), 2022-11-02
  • at Rigel Pharmaceuticals Inc (RIGL), 2022-05-23
  • Director at Brickell Biotech Inc. (BBI), 2022-05-17
  • Director at Travere Therapeutics Inc. (TVTX), 2022-05-13
  • Director at Eledon Pharmaceuticals Inc. (ELDN), 2022-02-02
  • Director at Cytori Therapeutics Inc. (CTYX), 2018-02-09
  • Director at Kalobios Pharmaceuticals Inc (KBIO), 2015-07-14
  • Director at Neurogesx Inc (NGSX), 2012-06-12
  • Director at Poniard Pharmaceuticals Inc. (PARD), 2011-07-12
  • Director at Facet Biotech Corp (FACT), 2010-04-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VICL $4.39 7,078 Director 14,906 2016-06-03 Filing
VICL $0.01 5,953 Director 63,281 2013-05-23 Filing
VICL $0.01 7,328 Director 57,328 2012-05-24 Filing
VICL $0.01 18,750 Director 50,000 2011-05-26 Filing
VICL $0.01 18,750 Director 31,250 2010-05-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
NBIX $114.76 15,000 Director 203,697 2022-10-31 Filing
NBIX $110.54 5,000 Director 203,697 2022-10-04 Filing
NBIX $92.76 15,000 Director 208,697 2022-04-25 Filing
NBIX $105.06 5,000 Director 208,697 2021-10-07 Filing
NBIX $100.27 10,000 Director 213,697 2021-06-10 Filing